Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer

Guardado en:
Detalles Bibliográficos
Autores principales: Leisha A Emens, Huilin Ma, Hanwen Wang, Richard J Sové, Aleksander S Popel
Formato: article
Lenguaje:EN
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://doaj.org/article/46662a33a2a04b4e89ceddf01ba602a9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:46662a33a2a04b4e89ceddf01ba602a9
record_format dspace
spelling oai:doaj.org-article:46662a33a2a04b4e89ceddf01ba602a92021-11-16T09:00:05ZQuantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer10.1136/jitc-2020-0021002051-1426https://doaj.org/article/46662a33a2a04b4e89ceddf01ba602a92021-02-01T00:00:00Zhttps://jitc.bmj.com/content/9/2/e002100.fullhttps://doaj.org/toc/2051-1426Leisha A EmensHuilin MaHanwen WangRichard J SovéAleksander S PopelBMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 2 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Leisha A Emens
Huilin Ma
Hanwen Wang
Richard J Sové
Aleksander S Popel
Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer
format article
author Leisha A Emens
Huilin Ma
Hanwen Wang
Richard J Sové
Aleksander S Popel
author_facet Leisha A Emens
Huilin Ma
Hanwen Wang
Richard J Sové
Aleksander S Popel
author_sort Leisha A Emens
title Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer
title_short Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer
title_full Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer
title_fullStr Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer
title_full_unstemmed Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer
title_sort quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer
publisher BMJ Publishing Group
publishDate 2021
url https://doaj.org/article/46662a33a2a04b4e89ceddf01ba602a9
work_keys_str_mv AT leishaaemens quantitativesystemspharmacologymodelpredictionsforefficacyofatezolizumabandnabpaclitaxelintriplenegativebreastcancer
AT huilinma quantitativesystemspharmacologymodelpredictionsforefficacyofatezolizumabandnabpaclitaxelintriplenegativebreastcancer
AT hanwenwang quantitativesystemspharmacologymodelpredictionsforefficacyofatezolizumabandnabpaclitaxelintriplenegativebreastcancer
AT richardjsove quantitativesystemspharmacologymodelpredictionsforefficacyofatezolizumabandnabpaclitaxelintriplenegativebreastcancer
AT aleksanderspopel quantitativesystemspharmacologymodelpredictionsforefficacyofatezolizumabandnabpaclitaxelintriplenegativebreastcancer
_version_ 1718426600124448768